| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |